<DOC>
	<DOCNO>NCT02487693</DOCNO>
	<brief_summary>The purpose study determine whether combine radiofrequency ablation ( RFA ) cytokine-induced killer cell ( CIK ) transfusion prolong survival patient ovarian carcinoma .</brief_summary>
	<brief_title>Radiofrquency Ablation Combined With Cytokine-induced Killer Cells Patients With Ovarian Carcinoma</brief_title>
	<detailed_description>The primary objective evaluate whether RFA follow CIK transfusion prolong survival patient ovarian carcinoma .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<criteria>1. patient diagnosed FIGO stage II ovarian carcinoma ; 2. cytoreductive surgery perform 6 course platinumbased chemotherapy complete ; 3. medical record maintain comprehensive data treatment followup ; 4. history previous malignancy . 1. neoadjuvant chemotherapy apply ; 2. less 6 course chemotherapy 6 course chemotherapy complete ; 3. medical record maintain incomplete data treatment followup ; 4. history previous malignancy .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>